Caribou Biosciences, Inc. Common Stock (NASDAQ: CRBU) last traded at $1.66, up 3.11% on the session. The quote above updates while this page is open; the figures below are drawn from Caribou Biosciences, Inc. Common Stock’s own filings and are restated only when a new one is published.
Caribou Biosciences, Inc. Common Stock trades on NASDAQ under the ticker CRBU. Its market capitalisation is $177.96 million.
Valuation measures for Caribou Biosciences, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $177.96M |
|---|---|
| Enterprise value | $196.44M |
| Price / sales | 17.73 |
| Price / book | 1.81 |
| Beta | 2.29 |
Trailing-twelve-month figures tagged in Caribou Biosciences, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $10.04M |
|---|---|
| Net income (TTM) | -$103.40M |
| EPS (TTM) | -$1.08 |
| Operating margin | -1090.90% |
| Return on equity | -105.40% |
| Cash | $26.19M |
Range and volume for CRBU over the past 52 weeks.
| 52-week high | $3.54 |
|---|---|
| 52-week low | $1.38 |
| Volume | 1.15M |
| Average volume | 1.85M |
| Previous close | $1.61 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.